The Root Cause Medicine Podcast · Rupa Health

New Advances in Cholesterol Testing & Treatment Dr. Eve Henry

·1 hr 5 min·4 clips

Cholesterol particles can hit an artery wall, get stuck, and trigger a plaque that can rupture.

Dr. Kate Kresge opens the episode with Dr. Eve Henry by framing the discussion around new advances in cholesterol testing and treatment. From there, the show gets specific fast. Advanced lipid panels are the starting point, but the real focus is on what those markers mean when a clinician has to make a decision. Cardiovascular disease comes up as the number one cause of preventable death in the U.S., which keeps the conversation grounded in risk reduction rather than theory. Dr. Eve explains that she looks beyond the standard cholesterol conversation when assessing risk. ApoB matters. LP little a matters. So do inflammatory markers like ferritin, CRP, and LPPLA2. The episode also notes that hemoglobin A1c may need to be interpreted differently depending on a client's typical pattern, which is a useful reminder that lab results do not always tell the whole story on their own. The genetic angle adds another layer. Dr. Eve describes using genetics to sort people into patterns that look more like cholesterol synthesis or cholesterol recycling, then using that information to think through medication choices and the lifestyle changes that might help first. The show does not pretend every case should be handled the same way. A client with very high baseline cholesterol and a sky high coronary calcium score is treated differently from someone with a lower ApoB, a negative CAC score, and no family history. In one case, medication is the clearest path. In the other, diet adjustments and time may be enough, or at least worth trying before moving faster. That contrast gives the episode most of its shape. It is less interested in rules than in judgment. The hosts also spend time on communication, especially how to explain a recommendation in plain language so it lands with the client instead of sounding like jargon. That part matters because the science is only useful if people can hear what it means for them. The overall tone stays steady and practical. Rather than treating advanced lipid work as a lab geek exercise, the episode keeps asking how to make it usable in real life. Listeners get a clear sense of why a clinician would care about these markers, how those details affect treatment, and where a thoughtful provider might still leave room to experiment. It ends up feeling like a working clinic conversation, not a lecture, which is probably why the episode works so well for both the science-curious and the treatment-facing listener. The takeaway is simple: cholesterol care gets better when markers, genetics, imaging, and urgency are read together instead of in isolation.

As heard by us

A practical look at modern cholesterol testing and treatment.

The episode treats newer cholesterol testing as a working clinical conversation, not a lecture built around jargon. Dr. Eve Henry and Dr. Kate Kresge walk through biomarkers and advanced lipid panels, including LP little a, ApoB, ferritin, CRP, and LPPLA2, and they also touch on…

Read the full review in PlayNext →

Why you'd press play

You want a clearer way to judge cholesterol risk beyond the standard panel.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Root Cause Medicine Podcast